{"title":"Management of adverse effects following additively manufactured subperiosteal jaw implantation in the maxilla.","authors":"Maurice Y Mommaerts","doi":"10.1016/j.jormas.2024.102206","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This expert opinion presents provisional guidelines for addressing complications associated with Additively Manufactured Subperiosteal Jaw Implants (AMSJI®) in patients with severe maxillary atrophy. AMSJI®'s custom design, supported by finite element analysis (FEA), allows precise placement that avoids critical anatomical structures and minimizes complications relative to alternative solutions.</p><p><strong>Materials and methods: </strong>Data were gathered through firsthand experiences, direct communications, two structured surveys and insights from international workgroup meetings.</p><p><strong>Results: </strong>Minor complications, such as soft tissue recession with inflammation, can be managed through thorough patient selection and early intervention. Severe complications, such as ascending infections and mechanical issues (e.g., fractures of implant components), have been rare. Compared to zygomatic implants and bone grafting, AMSJI® demonstrates a favorable safety profile. Zygomatic implants may lead to severe issues like orbital cellulitis and diplopia, while bone grafting risks include graft resorption, loss, and donor site complications. To mitigate risks, selecting patients carefully and ensuring diligent follow-up are critical, especially in those with risk factors like smoking or bruxism. Improved imaging, planning, and FEA have further contributed to minimizing complications, reinforcing AMSJI®'s role in complex maxillary reconstructions and implant-supported prosthetics.</p><p><strong>Conclusions: </strong>AMSJI® demonstrates high success rates but requires meticulous risk management. Key strategies involve carefully candidates by excluding those who are smokers, immunocompromised, or non-compliant, or diabetics with a history of infectious complications. Additionally, strict adherence to oral hygiene protocols is essential to optimize outcomes and minimize risks.Proactive management in these areas is crucial to optimize outcomes, ensure implant longevity, and support successful prosthetic rehabilitation.</p>","PeriodicalId":56038,"journal":{"name":"Journal of Stomatology Oral and Maxillofacial Surgery","volume":" ","pages":"102206"},"PeriodicalIF":2.2000,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Stomatology Oral and Maxillofacial Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jormas.2024.102206","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Dentistry","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: This expert opinion presents provisional guidelines for addressing complications associated with Additively Manufactured Subperiosteal Jaw Implants (AMSJI®) in patients with severe maxillary atrophy. AMSJI®'s custom design, supported by finite element analysis (FEA), allows precise placement that avoids critical anatomical structures and minimizes complications relative to alternative solutions.
Materials and methods: Data were gathered through firsthand experiences, direct communications, two structured surveys and insights from international workgroup meetings.
Results: Minor complications, such as soft tissue recession with inflammation, can be managed through thorough patient selection and early intervention. Severe complications, such as ascending infections and mechanical issues (e.g., fractures of implant components), have been rare. Compared to zygomatic implants and bone grafting, AMSJI® demonstrates a favorable safety profile. Zygomatic implants may lead to severe issues like orbital cellulitis and diplopia, while bone grafting risks include graft resorption, loss, and donor site complications. To mitigate risks, selecting patients carefully and ensuring diligent follow-up are critical, especially in those with risk factors like smoking or bruxism. Improved imaging, planning, and FEA have further contributed to minimizing complications, reinforcing AMSJI®'s role in complex maxillary reconstructions and implant-supported prosthetics.
Conclusions: AMSJI® demonstrates high success rates but requires meticulous risk management. Key strategies involve carefully candidates by excluding those who are smokers, immunocompromised, or non-compliant, or diabetics with a history of infectious complications. Additionally, strict adherence to oral hygiene protocols is essential to optimize outcomes and minimize risks.Proactive management in these areas is crucial to optimize outcomes, ensure implant longevity, and support successful prosthetic rehabilitation.
期刊介绍:
J Stomatol Oral Maxillofac Surg publishes research papers and techniques - (guest) editorials, original articles, reviews, technical notes, case reports, images, letters to the editor, guidelines - dedicated to enhancing surgical expertise in all fields relevant to oral and maxillofacial surgery: from plastic and reconstructive surgery of the face, oral surgery and medicine, … to dentofacial and maxillofacial orthopedics.
Original articles include clinical or laboratory investigations and clinical or equipment reports. Reviews include narrative reviews, systematic reviews and meta-analyses.
All manuscripts submitted to the journal are subjected to peer review by international experts, and must:
Be written in excellent English, clear and easy to understand, precise and concise;
Bring new, interesting, valid information - and improve clinical care or guide future research;
Be solely the work of the author(s) stated;
Not have been previously published elsewhere and not be under consideration by another journal;
Be in accordance with the journal''s Guide for Authors'' instructions: manuscripts that fail to comply with these rules may be returned to the authors without being reviewed.
Under no circumstances does the journal guarantee publication before the editorial board makes its final decision.
The journal is indexed in the main international databases and is accessible worldwide through the ScienceDirect and ClinicalKey Platforms.